» Articles » PMID: 36142773

Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Sep 23
PMID 36142773
Authors
Affiliations
Soon will be listed here.
Abstract

The development of smart immune evasion mechanisms is crucial for the establishment of acute and chronic viral hepatitis. Hepatitis is a major health problem worldwide arising from different causes, such as pathogens, metabolic disorders, and xenotoxins, with the five hepatitis viruses A, B, C, D, and E (HAV, HBV, HCV, HDV, and HEV) representing the majority of the cases. Most of the hepatitis viruses are considered enveloped. Recently, it was reported that the non-enveloped HAV and HEV are, in reality, quasi-enveloped viruses exploiting exosomal-like biogenesis mechanisms for budding. Regardless, all hepatitis viruses use exosomes to egress, regulate, and eventually escape from the host immune system, revealing another key function of exosomes apart from their recognised role in intercellular communication. This review will discuss how the hepatitis viruses exploit exosome biogenesis and transport capacity to establish successful infection and spread. Then, we will outline the contribution of exosomes in viral persistence and liver disease progression.

Citing Articles

A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.

Ebrahimi F, Modaresi Movahedi A, Sabbaghian M, Poortahmasebi V Health Sci Rep. 2024; 7(11):e70196.

PMID: 39558933 PMC: 11570872. DOI: 10.1002/hsr2.70196.


An In-Depth Approach to the Associations between MicroRNAs and Viral Load in Patients with Chronic Hepatitis B-A Systematic Review and Meta-Analysis.

Manea M, Maruntelu I, Constantinescu I Int J Mol Sci. 2024; 25(15).

PMID: 39125978 PMC: 11313658. DOI: 10.3390/ijms25158410.


Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy.

Adugna A, Muche Y, Melkamu A, Jemal M, Belew H, Amare G Heliyon. 2024; 10(14):e34288.

PMID: 39100497 PMC: 11295980. DOI: 10.1016/j.heliyon.2024.e34288.


Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.

Zhang M, Yuan Y, Liu L, Wei Y, Yin W, Zheng L World J Gastroenterol. 2023; 29(31):4706-4735.

PMID: 37664153 PMC: 10473924. DOI: 10.3748/wjg.v29.i31.4706.

References
1.
Skryabin G, Komelkov A, Savelyeva E, Tchevkina E . Lipid Rafts in Exosome Biogenesis. Biochemistry (Mosc). 2020; 85(2):177-191. DOI: 10.1134/S0006297920020054. View

2.
McKnight K, Xie L, Gonzalez-Lopez O, Rivera-Serrano E, Chen X, Lemon S . Protein composition of the hepatitis A virus quasi-envelope. Proc Natl Acad Sci U S A. 2017; 114(25):6587-6592. PMC: 5488923. DOI: 10.1073/pnas.1619519114. View

3.
Trepo C . A brief history of hepatitis milestones. Liver Int. 2013; 34 Suppl 1:29-37. DOI: 10.1111/liv.12409. View

4.
Metzner C, Zaruba M . On the Relationship of Viral Particles and Extracellular Vesicles: Implications for Viral Vector Technology. Viruses. 2021; 13(7). PMC: 8310354. DOI: 10.3390/v13071238. View

5.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View